A 68-year-old man with severe septic shock and refractory hypotension (BP 70/45 mmHg despite 2 L crystalloid bolus) presents to the ICU. Heart rate is 118/min, urine output 0.2 mL/kg/hr, and lactate is 6.2 mmol/L. Noradrenaline infusion is initiated at 0.05 mcg/kg/min. Despite escalation to 0.3 mcg/kg/min over 2 hours, systolic BP remains 75 mmHg and organ perfusion markers are worsening. What is the most appropriate next step in management?

Explanation

## Clinical Context: Catecholamine-Refractory Septic Shock This patient demonstrates **refractory hypotension** despite adequate fluid resuscitation and escalating doses of noradrenaline — a hallmark of severe septic shock requiring combination vasopressor therapy. ## Rationale for Combination Vasopressor Therapy **Key Point:** Current Surviving Sepsis Campaign (SSC) guidelines recommend adding a second vasopressor when the target MAP cannot be achieved with noradrenaline monotherapy at moderate-to-high doses (0.3 mcg/kg/min or higher). **High-Yield:** The sequential approach to septic shock vasopressor management is: 1. Noradrenaline as first-line (α1 + β1 effects → vasoconstriction + inotropy) 2. Add **vasopressin (0.03–0.04 units/min fixed dose)** OR **epinephrine** when noradrenaline alone fails 3. Consider hydrocortisone only if refractory shock persists despite dual vasopressors ## Why Combination Works | Agent | Primary Effect | Rationale for Addition | |-------|----------------|------------------------| | Noradrenaline | α1 + β1 | Restores perfusion pressure | | Vasopressin | V1 receptor | Synergistic vasoconstriction; no tachycardia | | Epinephrine | α1 + β1 + β2 | Stronger inotropy if cardiac output is limiting | **Clinical Pearl:** Vasopressin is preferred as the **second agent** in septic shock because it avoids further tachycardia (unlike epinephrine) and has a fixed dose independent of body weight, simplifying titration in ICU. ## Mechanism of Adrenergic Synergy Noradrenaline + vasopressin create a **multimodal vasopressor effect**: - Noradrenaline: α1-mediated vasoconstriction + β1-mediated contractility - Vasopressin: V1-mediated vasoconstriction + preservation of organ perfusion - Combined: improved MAP and microvascular flow without excessive tachycardia **Tip:** Remember that **refractory shock = dual vasopressor therapy**, not monotherapy escalation or steroid initiation as first step.